Solu-medrol Injection, Powder, For Solution
NDC Package 71872-7232-1
Package Information
Solu-medrol (methylprednisolone sodium succinate) injection is a medication used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Medical Purchasing Solutions, Llc, this product is identified by NDC 71872-7232 and is authorized under FDA application NDA011856.
Identification & Billing
- RxCUI: 1743704 - methylPREDNISolone sodium succinate 125 MG Injection
- RxCUI: 1743704 - methylprednisolone 125 MG Injection
- RxCUI: 1743704 - methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection
- RxCUI: 1743707 - SOLU-Medrol 125 MG Injection
- RxCUI: 1743707 - methylprednisolone 125 MG Injection [Solu-Medrol]
Clinical Specifications
- Intramuscular - Administration within a muscle.
- Intravenous - Administration within or into a vein or veins.
Regulatory & Marketing
Hierarchy Structure
- 71872 - Medical Purchasing Solutions, Llc
- 71872-7232 - Solu-medrol
- 71872-7232-1 - 1 VIAL in 1 BAG / 2 mL in 1 VIAL
- 71872-7232 - Solu-medrol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71872-7232-1 identifies a specific commercial package of 1 vial in 1 bag / 2 ml in 1 vial of Solu-medrol, a human prescription drug labeled by Medical Purchasing Solutions, Llc. This injection, powder, for solution is formulated for intramuscular; intravenous use and contains methylprednisolone sodium succinate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medical Purchasing Solutions, Llc on April 02, 1959. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. Methylprednisolone is a corticosteroid hormone. This injectable form of methylprednisolone is used when a similar drug cannot be taken by mouth or when a very fast response is needed, especially in patients with severe medical conditions. Talk to your doctor about the risks and benefits of methylprednisolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. Methylprednisolone may also be used with other medications in hormone disorders.
How is this Medical Purchasing Solutions, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71872723201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.